The FBXW7 β-form is suppressed in human glioma cells

Abstract FBXW7 (F-box and WD40 domain protein 7) is an F-box protein with 7 tandem WDs (tryptophan–aspartic acid) that functions as a phosphoepitope-specific substrate recognition component of SCF (Skp1–Cul1–F-box protein) ubiquitin ligases and catalyzes the ubiquitination of proteins promoting cell proliferation, such as CCNE1, MYC, AURKA, NOTCH1, and JUN, which are frequently activated in a wide range of human cancers. FBXW7 is a candidate tumor suppressor, and mutations have been reported in some human tumors. In this study, we analyzed 84 human tumor cell lines in search for genetic alterations of FBXW7, as well as mRNA and protein expressional changes, and compared them with expression levels of the CCNE1, MYC, and AURKA proteins. We found a novel nonsense mutation in a colon cancer cell line SCC and confirmed the missense mutations in SKOV3, an ovarian cancer cell line, and LoVo, a colon cancer cell line. Moreover, suppressed expression of FBXW7 accompanied by activation of the target proteins were observed in ovarian, colon, endometrial, gastric, and prostate cancers. It is notable that highly suppressed mRNA expression of the FBXW7 β-form was found in all the human glioma cell lines analyzed; enhanced expressions of CCNE1, MYC, and AURKA were observed in these cells. Our present results imply that FBXW7 plays a pivotal role in many tissues by controlling the amount of cell cycle promoter proteins and that dysfunction of this protein is one of the essential steps in carcinogenesis in multiple organs.

[1]  Sho Hashimoto,et al.  APAF-1-ALT, a novel alternative splicing form of APAF-1, potentially causes impeded ability of undergoing DNA damage-induced apoptosis in the LNCaP human prostate cancer cell line. , 2003, Biochemical and biophysical research communications.

[2]  M. Tsao,et al.  Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. , 1996, The American journal of pathology.

[3]  A. Ciechanover,et al.  The ubiquitin system. , 1998, Annual review of biochemistry.

[4]  S. Elledge,et al.  Phosphorylation-Dependent Ubiquitination of Cyclin E by the SCFFbw7 Ubiquitin Ligase , 2001, Science.

[5]  Allan Balmain,et al.  Fbxw7/Cdc4 is a p53-dependent, haploinsufficient tumour suppressor gene , 2004, Nature.

[6]  T. Furukawa,et al.  Abrogation of DUSP6 by hypermethylation in human pancreatic cancer , 2005, Journal of Human Genetics.

[7]  T. Furukawa,et al.  Adenovirus-mediated transfer of p33ING1 with p53 drastically augments apoptosis in gliomas. , 1999, Cancer research.

[8]  A. Sakurada,et al.  Expression of the DMBT1 Gene Is Frequently Suppressed in Human Lung Cancer , 1999, Japanese journal of cancer research : Gann.

[9]  A. Sakurada,et al.  Adenovirus-mediated delivery of the PTEN gene inhibits cell growth by induction of apoptosis in endometrial cancer. , 1999, International journal of oncology.

[10]  M. Gurney,et al.  SEL-10 Is an Inhibitor of Notch Signaling That Targets Notch for Ubiquitin-Mediated Protein Degradation , 2001, Molecular and Cellular Biology.

[11]  A. Horii,et al.  The human PMS2L proteins do not interact with hMLH1, a major DNA mismatch repair protein. , 1999, Journal of biochemistry.

[12]  J. Cigudosa,et al.  Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma , 2003, The Journal of pathology.

[13]  Akinobu Matsumoto,et al.  Fbxw7 contributes to tumor suppression by targeting multiple proteins for ubiquitin‐dependent degradation , 2006, Cancer science.

[14]  Mike Tyers,et al.  F-Box Proteins Are Receptors that Recruit Phosphorylated Substrates to the SCF Ubiquitin-Ligase Complex , 1997, Cell.

[15]  A. Horii,et al.  Alternative splicing of hMSH2 in normal human tissues , 1997, Human Genetics.

[16]  H. J. Kim,et al.  Mutational analysis of the hCDC4 gene in gastric carcinomas. , 2006, European journal of cancer.

[17]  B. Clurman,et al.  The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Sato,et al.  Chromosome band 16q24 is frequently deleted in human gastric cancer , 1999, British Journal of Cancer.

[19]  A. Horii,et al.  Exploration of genetic alterations in human endometrial cancer and melanoma: distinct tumorigenic pathways that share a frequent abnormal PI3K/AKT cascade. , 2005, Oncology reports.

[20]  Carlo Rago,et al.  Inactivation of hCDC4 can cause chromosomal instability , 2004, Nature.

[21]  S. Reed,et al.  Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line , 2001, Nature.

[22]  T. Furukawa,et al.  Identification of two common regions of allelic loss in chromosome arm 12q in human pancreatic cancer. , 1998, Cancer research.

[23]  A. Horii,et al.  Detailed deletion mapping on chromosome arm 12q in human pancreatic adenocarcinoma: Identification of a 1‐cM region of common allelic loss , 1996, Genes, chromosomes & cancer.

[24]  O. Sieber,et al.  CDC4 mutations occur in a subset of colorectal cancers but are not predicted to cause loss of function and are not associated with chromosomal instability. , 2005, Cancer research.

[25]  R. Hruban,et al.  BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets. , 2003, The American journal of pathology.

[26]  Dejan Juric,et al.  Functional network analysis reveals extended gliomagenesis pathway maps and three novel MYC-interacting genes in human gliomas. , 2005, Cancer research.

[27]  T. Ono,et al.  Infrequent Genetic Alterations of the PTEN/MMAC1 Gene in Japanese Patients with Primary Cancers of the Breast, Lung, Pancreas, Kidney, and Ovary , 1997, Japanese journal of cancer research : Gann.

[28]  S. Reed,et al.  hCDC4 gene mutations in endometrial cancer. , 2002, Cancer research.

[29]  T. Akiyama,et al.  Infrequent somatic mutations of the ICAT gene in various human cancers with frequent 1p-LOH and/or abnormal nuclear accumulation of beta-catenin. , 2004, Oncology reports.

[30]  D. Haber,et al.  Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer. , 2005, Gynecologic oncology.

[31]  Suna Wang,et al.  Mutational and LOH Analyses of the Chromosome 4q Region in Esophageal Adenocarcinoma , 2006, Oncology.

[32]  A. Behrens,et al.  The Ubiquitin Ligase SCFFbw7 Antagonizes Apoptotic JNK Signaling , 2004, Science.

[33]  Daniel A. Haber,et al.  Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines , 2001, Nature.

[34]  E. Soeda,et al.  Genomic analysis of DUSP6, a dual specificity MAP kinase phosphatase, in pancreatic cancer , 1998, Cytogenetic and Genome Research.

[35]  Kazuhiro Takahashi,et al.  BRAF point mutations in primary melanoma show different prevalences by subtype. , 2004, The Journal of investigative dermatology.

[36]  Leonid Kruglyak,et al.  A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. , 2002, American journal of human genetics.